INTRODUCTION {#sec1-1}
============

Epidermoid tumors (ETs) are rare benign lesions of embryonic origin; they represent nearly 0.5% of all intracranial lesions.\[[@ref11]\]

It is believed that the origin of these tumors results from the inclusion of ectoderm cells at the time of the closure of the neural tube between the 3^rd^ and 5^th^ week of embryonic life.\[[@ref11]\]

ETs are most commonly located intracranially in the cerebellopontine angle (CPA),\[[@ref9][@ref13]\] and frequently present with cranial nerve symptoms; hyperactive dysfunction of cranial nerves, such as trigeminal neuralgia and hemifacial spasm, is a common symptom of patients with CPA ETs.\[[@ref16]\]

Surgical resection with the preservation of neurological function is the standard of care for intracranial ET. However, complete resection of the lesion is not always possible, adherence to the lesion walls to important neurovascular structures makes achieving this goal, nearly impossible in some instances.\[[@ref1][@ref16]\]

Radiotherapy has not been used extensively to treat ET, but several reports of its efficacy have been published.\[[@ref5][@ref7][@ref12]\] Even fewer cases treated with radiosurgery have been reported.

We show a series of three cases of ET presenting with cranial nerve dysfunction treated with gamma knife radiosurgery (GKS), and the results obtained by the patients.

CASE REPORTS {#sec1-2}
============

Case 1 {#sec2-1}
------

A 21-year-old female patient presented with a headache, vertigo, tinnitus, and gait ataxia. Magnetic resonance imaging (MRI) revealed a heterogeneous lesion located in the left CPA, which was compatible with an ET. The lesion was in close relationship with the fifth, sixth, and seventh cranial nerves, and was displacing the brainstem contralaterally.

The patient was offered surgery but refused treatment, and so GKS was offered as an alternative.

The tumor had a total volume of 7.1cc and was treated in a single session with a dose of 15 Gy at 55% margin isodose, maximum dose of 27.3 Gy \[[Figure 1](#F1){ref-type="fig"}\].

![Treatment plan for a cerebellopontine angle epidermoid tumor, the tumor was covered by 15 Gy at a 55% isodose line. One percent of the brainstem received 8 Gy, the pineal gland received 9 Gy](SNI-7-116-g001){#F1}

At the follow-up period of 46 months, the patient had significant improvement of vertigo and tinnitus, with a headache remaining with similar characteristics. MRI at 6 months after surgery showed no significant changes.

Case 2 {#sec2-2}
------

A 59-year-old female patient with 10 years history of trigeminal neuralgia secondary to a documented ET that was surgically treated at that time. The patient showed improvement of her pain symptoms but recurred after 6 years, she was then taken to surgery once more, but because of scar tissue in the CPA removal of the lesion was not possible; she had a VII and VIII nerve injury during the second procedure.

Neuropathic pain in the third branch of the trigeminal nerve was persistent and refractory to multiple medical therapies. The patient was referred to our institution for GKS treatment.

On MRI, residual lesion in the left CPA in close relationship with the trigeminal nerve.

The patient was treated for trigeminal neuralgia with 80 Gy hotspot on the nerve while the tumor received 12 Gy margin dose \[[Figure 2](#F2){ref-type="fig"}\].

![Treatment plan for a patient with an epidermoid tumor and associated trigeminal neuralgia. 80 Gy hotspot was placed on the nerve while modeling 12 Gy isodose around the tumor. The optic pathway received 1.5 Gy on 1% of its volume; brainstem received 9 Gy on 1% of its total volume, and the pineal gland received a total of 1.7 Gy](SNI-7-116-g002){#F2}

Follow-up period of 33 moths showed that the patient had significant improvement of the pain; she developed paresthesia in the territory of V3 and continued medical therapy with carbamazepine achieving acceptable symptom control.

Tumor volume remained unchanged in control images.

Case 3 {#sec2-3}
------

A 29-year-old male patient, with a 6-year long case of trigeminal neuralgia, was treated medically with poor results; the pain was persistent and incapacitating.

An MRI study showed a lesion located in the CPA that was in close relationship with the V, VI, VII, and VII nerves.

Surgery was considered in this patient, but because of the low morbidity associated with GKS, a trial treatment was done with the intent of pain resolution and tumor growth control.

For this patient, treatment was addressed to improve pain as well, so a hotspot of 80 Gy was placed on the trigeminal nerve, meanwhile, the tumor margin received a dose of 12 Gy. The tumor had a total volume of 5.8cc \[[Figure 3](#F3){ref-type="fig"}\].

![Treatment plan for a cerebellopontine angle epidermoid tumor causing trigeminal neuralgia. An 80 Gy hotspot was placed on the trigeminal nerve, and a 12 Gy isodose curve was modeled around the tumor. At risk structures including the brainstem received only 8 Gy at 7% of its total volume](SNI-7-116-g003){#F3}

The patient was followed after 34 months; the pain had completely gone away and received no medical treatment. Control images showed no tumor growth.

DISCUSSION {#sec1-3}
==========

ETs are most frequently found in the CPA, and cranial nerve dysfunction is a common presenting symptom. Trigeminal neuralgia in patients with CPA ETs has been reported to vary from 0% to 76.9% depending on the series.\[[@ref2][@ref4][@ref6][@ref9]\] Because of its location, CPA epidermoids also present with disturbances of the VII and VIII cranial nerves, hemifacial spasm is seen in almost 10% of the patients and tinnitus with hearing loss can be seen in 3--6% of cases.\[[@ref3][@ref9]\]

Surgical resection is the main treatment for symptomatic tumors, and many active trials have been reported.\[[@ref14][@ref15]\] Since the tumor cells do exist in the tumor capsule, it is necessary to remove the tumor capsule to prevent recurrence of these lesions, which result in worsening of the symptoms. However, these operative procedures are not easy and may be harmful because the membrane can attach itself to the cranial nerves and brainstem.

Samii *et al*. presented his experience with surgical resection of posterior fossa ET, achieving complete resection in 30 of the 40 cases presented.\[[@ref14]\] Kobata *et al*.\[[@ref9]\] presented 30 cases of surgically treated CPA ETs, they obtained excellent and good results in all of the cases, although cranial nerve injury in some extend was reported in 18 of the 30 treated patients. Partial removal of a lesion leads to recurrence, which often occurs after a prolonged period as a result of the slow growth rate of the tumor.\[[@ref1][@ref10]\]

For patients who have failed surgical treatment or recurrence is documented, radiotherapy has been used as an alternative with fairly good results. The effects of radiotherapy on ET have been assessed in a few case reports,\[[@ref5][@ref7][@ref12]\] and tumor control, as the main goal, can be achieved by this method, with relatively low complications.

Davies *et al*. presented a series of three cases of ET that recurred after surgery; they treated these patients with conventional radiotherapy with doses varying from 45 Gy to 54 Gy given at 1.8 Gy per daily fraction. Patients achieved tumor and symptom control with a mean follow-up period of 33 months.

We believe that the option of radiosurgery should be given to the patients and should be considered for patients in whose surgery is not the best options or patients who refuse surgical treatment.

We present the three cases of ET causing cranial nerve dysfunction, two patients presented with trigeminal neuralgia, and one patient showed VIII nerve dysfunction with tinnitus and vertigo. All three patients were treated with GKS and showed significant improvement in their symptoms, and after 46 months of follow-up no recurrence has been reported \[[Table 1](#T1){ref-type="table"}\].

###### 

Characteristics of patients treated with GKS

![](SNI-7-116-g004)

Only one case series of ET treated with GKS could be found on this literature search. Kida *et al*.\[[@ref8]\] reported seven cases of CPA ETs presenting with cranial nerve dysfunction, including hemifacial spasm and trigeminal neuralgia. All patients treated by this group showed complete relief or improvement of their symptoms after 56 months of follow-up; they concluded that nerve decompression by means of GKS is achievable. [Table 2](#T2){ref-type="table"} shows comparative results of surgery, radiotherapy, and gamma knife radiosurgery.

###### 

Long-term results of different treatment methods for epidermoid tumors

![](SNI-7-116-g005)

It should be noted that in this case series an additional boost was delivered to the trigeminal nerve, and pain control was achieved, while in the case series presented by Kida *et al*., no additional radiation was given to the nerve, and still pain control was achieved. This might indicate that pain control may be the result of nerve decompression without the need of nerve lesion by means of direct radiosurgery.

We hope that this case series encourages other gamma knife groups to treat patients with ET, and by doing this, sufficient evidence is obtained so that radiosurgery can be used as a viable alternative for patients with ET and secondary cranial nerve dysfunction.

CONCLUSION {#sec1-4}
==========

We have shown three different cases of cranial nerve hyperactive dysfunction caused by CPA ETs. Long-term symptom relief was achieved in all three cases proving that GKS is a good and safe alternative for patients with recurrent or nonsurgically treated ET.
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